'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Bio Medica Laboratories Limited
BMLL (NSE) · ISIN INE1BKA01015 · Pharmaceuticals · listed 2026
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹26.4 cr | ₹22.89 cr | ₹57.46 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 67.70% | 4.77% | 3.61% | 32.30% |
Latest filings
- SDD Certificate as per Regulation3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 21 October 2026 · NSE
- Annual Report FY2025-26 (New) 4 September 2026 · NSE
- Bio Medica Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026. 2 September 2026 · NSE
- Bio Medica Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on August 14, 2026. 14 August 2026 · NSE
- Bio Medica Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. 27 July 2026 · NSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.